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Promoting Drp1-mediated mitochondrial ﬁssion in
midlife prolongs healthy lifespan of Drosophila
melanogaster
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The accumulation of dysfunctional mitochondria has been implicated in aging, but a deeper
understanding of mitochondrial dynamics and mitophagy during aging is missing. Here, we
show that upregulating Drp1—a Dynamin-related protein that promotes mitochondrial
ﬁssion—in midlife, prolongs Drosophila lifespan and healthspan. We ﬁnd that short-term
induction of Drp1, in midlife, is sufﬁcient to improve organismal health and prolong lifespan,
and observe a midlife shift toward a more elongated mitochondrial morphology, which is
linked to the accumulation of dysfunctional mitochondria in aged ﬂight muscle. Promoting
Drp1-mediated mitochondrial ﬁssion, in midlife, facilitates mitophagy and improves both
mitochondrial respiratory function and proteostasis in aged ﬂies. Finally, we show that
autophagy is required for the anti-aging effects of midlife Drp1-mediated mitochondrial ﬁs-
sion. Our ﬁndings indicate that interventions that promote mitochondrial ﬁssion could delay
the onset of pathology and mortality in mammals when applied in midlife.
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M itochondrial dysfunction is a key hallmark of aging andhas been linked to numerous age-onset pathologies1–3.Therefore, identifying interventions that could improve
mitochondrial homeostasis when targeted to aged animals would
be highly desirable toward the goal of prolonging healthspan. A
growing body of data support the idea that autophagy has an
important anti-aging role4, 5. However, the relevant autophagic
cargo in the context of aging remains elusive. Mitochondrial
autophagy (mitophagy) is a type of cargo-speciﬁc autophagy6, 7,
which mediates the removal of dysfunctional mitochondria. The
molecular mechanisms of mitophagy have been elucidated in
some detail in recent years8. Upon loss of inner mitochondrial
membrane potential, PINK1, a mitochondrial kinase, is selectively
stabilized on the surface of the dysfunctional mitochondrion,
leading to the recruitment of the E3 ubiquitin ligase Parkin9.
Upon mitochondrial recruitment, Parkin ubiquitinates mito-
chondrial outer membrane proteins10–14 and induces the autop-
hagic elimination of the dysfunctional mitochondrion6–8.
Recent studies in mammals, including humans, have reported
an age-related decline in mitophagy15, 16. Moreover, impairment
of mitophagy recapitulates the age-related accumulation of
mitochondria in Caenorhabditis elegans17. These ﬁndings suggest
that the mitophagy pathway may represent a therapeutic target to
counteract aging. Consistent with this idea, overexpression of
Parkin delays the onset of molecular markers of aging and pro-
longs lifespan in Drosophila18. Furthermore, dietary urolithin A
(UA) treatment induces mitophagy, prevents the age-related
accumulation of dysfunctional mitochondria and prolongs
C. elegans lifespan19. UA treatment also improves exercise
capacity in rodent models of age-related decline of muscle
function19. Together, these ﬁndings support the idea that
impaired mitophagy is a signiﬁcant underlying factor in the
accumulation of dysfunctional mitochondria in aged animals
contributing to organismal health decline and mortality.
However, a major unanswered question remains: why does
mitophagy decline in aged animals?
Mitochondrial dynamics (ﬁssion and fusion) and mitophagy
are closely related7, 8, 20, 21. Mitochondrial ﬁssion and fusion
processes are both mediated by large guanosine triphosphatases
(GTPases) in the dynamin family22, 23. Mitofusin (Mfn) proteins
mediate fusion of the mitochondrial outer membrane, while
mitochondrial ﬁssion, conversely, requires Dynamin-related
protein 1 (Drp1)22, 24. Several studies indicate that an impor-
tant event preceding mitophagy is the Parkin-mediated turnover
of Mfn leading to a shift in the balance of mitochondrial
dynamics toward decreased fusion/increased ﬁssion7, 20. In yeast,
the mitochondrial ﬁssion protein, Dnm1, homologous to Drp1,
is required for certain forms of mitophagy25–27. Together, these
ﬁndings support the model that mitochondrial ﬁssion can pro-
mote the segregation of damaged mitochondria and facilitate
their clearance by mitophagy7, 11, 12, 28, 29. Critically, however, the
interplay between mitochondrial dynamics and mitophagy during
aging remains poorly understood.
The anti-aging effects of Parkin overexpression in Drosophila18
and UA treatment in C. elegans19 are both associated with an
increase in mitochondrial ﬁssion. Critically, however, the ques-
tion of whether an increase in mitochondrial ﬁssion alone is
sufﬁcient to prolong lifespan and/or improve mitochondrial
function in an aged animal has not been addressed. Here,
we show that inducing Drp1-mediated mitochondrial ﬁssion,
in midlife, increases lifespan and improves multiple markers of
health in aged Drosophila. Remarkably, we show that a transient
induction of Drp1, for 7 days, in midlife is sufﬁcient to prolong
lifespan. Studying aging ﬂight muscle, we ﬁnd that a midlife shift
toward a more elongated, less circular mitochondrial morphology
is linked to the accumulation of dysfunctional mitochondria.
Short-term, midlife Drp1 induction restores mitochondrial
morphology to a youthful state, improves mitochondrial
respiratory function and reduces mitochondrial reactive oxygen
species (ROS) levels. Importantly, midlife Drp1 induction facil-
itates mitophagy and improves proteostasis in aged ﬂies. Finally,
we show that disruption of Atg1, a core autophagy gene, inhibits
the anti-aging, prolongevity effects of midlife Drp1 induction.
Our ﬁndings indicate that transient, midlife interventions that
promote mitochondrial ﬁssion could delay the onset of frailty and
mortality in aging mammals.
Results
Midlife Drp1 induction prolongs lifespan and healthspan. In
previous work, we showed that long-lived Parkin overexpressing
ﬂies display an increase in mitochondrial ﬁssion18. To test for a
causal role for mitochondrial ﬁssion in lifespan extension,
we sought to independently promote mitochondrial ﬁssion by
upregulating Drp1 in aging ﬂies. To do so, we used the ubiquitous
daughterless-Gene-Switch (daGS) driver line to activate a
UAS-Drp1 transgene created by30. Western blot and immuno-
ﬂuorescence analysis conﬁrmed a dose-dependent and RU486-
dependent induction of the Drp1 transgene (Supplementary
Fig. 1a–d). Next, we conﬁrmed that Drp1 induction confers a
shift in mitochondrial dynamics toward increased ﬁssion in adult
ﬂies in both muscle and brain tissue (Fig. 1a–c). Next, we set out
to examine the impact of temporally-deﬁned shifts in mito-
chondrial dynamics on ﬂy lifespan. Upregulation of Drp1 in early
adulthood (days 0–30) or throughout adulthood had no sig-
niﬁcant impact on longevity (Fig. 1d, Supplementary Table 1).
However, upregulating Drp1 from midlife (day 30) onwards
signiﬁcantly extended lifespan in both male and female ﬂies
(Fig. 1e, Supplementary Fig. 1e, f; Supplementary Table 1). Using
an independently generated UAS-Drp1 transgene31, we conﬁrmed
that midlife Drp1 induction prolongs lifespan (Supplementary
Fig. 1g; Supplementary Table 1). To further examine the impact
of manipulating mitochondrial dynamics in midlife, we examined
the impact of RNAi of Drosophila (d)Mfn on lifespan.
Importantly, we observed that RNAi of dMfn from midlife
onwards also extends both mean and maximum lifespan (Fig. 1f;
Supplementary Table 1). Taken together, our ﬁndings demon-
strate that promoting mitochondrial ﬁssion/inhibiting fusion
from midlife onwards prolongs ﬂy lifespan. To further validate
our ﬁndings, we examined the impact of inhibiting mitochondrial
ﬁssion/promoting mitochondrial fusion in midlife on ﬂy lifespan.
Importantly, we observed that expression of a dominant-negative
Drp1 (Drp1K38A) transgene30 from midlife onwards shortens
lifespan (Supplementary Fig. 1h; Supplementary Table 1) and
upregulation of dMfn in midlife also shortens lifespan
(Supplementary Fig. 1i; Supplementary Table 1). To reﬁne the
tissue-speciﬁc requirements involved in Drp1-mediated lifespan
extension, we used the pan-neuronal Elav–Gene-Switch (ElavGS)
driver line to increase Drp1 expression speciﬁcally in neurons32
and 5966-GS33 to increase Drp1 gene expression in the intestine.
Upregulating Drp1 speciﬁcally in neurons or the intestine
from midlife onwards is sufﬁcient to prolong ﬂy lifespan
(Supplementary Fig. 1j, k; Supplementary Table 1).
To reﬁne the temporal requirements involved, we tested
whether a transient induction of Drp1 was sufﬁcient to prolong
lifespan. We found that short-term induction of Drp1, from day
30 to 37, produced a robust increase in both mean and maximum
lifespan (Fig. 1g, Supplementary Fig. 1l; Supplementary Table 1).
Importantly, we ﬁnd that Drp1 mRNA levels do not remain
elevated following short-term midlife induction (Fig. 1h). RU486
had no impact on mitochondrial morphology, Drp1 mRNA levels
or longevity in control ﬂies when fed at any time period
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(Supplementary Figs 1m–p and 3d, e). Because ubiquitous,
midlife Drp1 induction in female ﬂies resulted in the most
pronounced extension of lifespan, this paradigm was used in all
further experiments.
To better understand the impact of Drp1-mediated mitochon-
drial ﬁssion in midlife on organismal health, we examined a
number of markers of healthspan and behavior in aged ﬂies
following 7 days of Drp1 induction. As a reduction in food intake
can modulate lifespan, we tested whether midlife Drp1 induction
affects feeding behavior. Using a capillary feeding assay34, we
failed to observe alterations in feeding behavior upon short-term,
midlife Drp1 induction (Fig. 2a). It is important to determine
whether interventions that prolong lifespan also extend health-
span or simply prolong a period of frailty. Short-term, midlife
Drp1 induction conferred an increase in spontaneous physical
activity (Fig. 2b and c). Importantly, this increase in physical
activity was conﬁned to day-time activity, as opposed to night
time restlessness. Moreover, short-term, midlife Drp1 induction
produced a signiﬁcant improvement in an endurance exercise
paradigm (Fig. 2d). The ability to withstand extrinsic stress is a
marker of organismal health that declines with age. Short-term,
midlife Drp1 induction improved survival when maintained on
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Fig. 1 Midlife Drp1 induction extends lifespan. a, b Immunostaining of indirect ﬂight muscles a from 37 day old daGS>UAS-Drp1 females with or without
RU486-mediated transgene induction for 7 days from day 30 to day 37, showing mitochondria (green channel, anti-ATP5a) and Drp1 (red channel, anti-
Drp1). Scale bar is 5 µm. Quantiﬁcation of mitochondrial size b; n= 7 individual thoraces; ***p< 0.001; two-tailed unpaired t-test. c Immunostaining of optic
lobe/brain from 37 day old daGS>UAS-Drp1 females with or without RU486-mediated transgene induction for 7 days from day 30 to day 37, showing
mitochondria (green channel, anti-ATP5a) and nuclei (blue channel, TO-PRO-3). Scale bar is 5 µm. d Survival curves of daGS>UAS-Drp1 females with or
without RU486-mediated transgene induction from day 1 to day 30. The shaded area indicates the duration of Drp1 induction. p= 0.42, log-rank test;
n> 179 ﬂies. e Survival curves of daGS>UAS-Drp1 females with or without RU486-mediated transgene induction from day 30 onwards. The shaded area
indicates the duration of Drp1 induction. p< 0.0001, log-rank test; n> 179 ﬂies. f Survival curves of daGS>UAS-dMfn-RNAi females with or without RU486-
mediated transgene induction from day 30 onwards. The shaded area indicates the duration of dMfn RNAi. p< 0.0001, log-rank test; n> 175 ﬂies. g Survival
curves of daGS> UAS-Drp1 females with or without RU486-mediated transgene induction from day 30 to day 37. The shaded area indicates the duration of
Drp1 induction. p< 0.0001, log-rank test; n> 291 ﬂies. h qPCR analyses of Drp1 mRNA levels on day 44 in daGS>UAS-Drp1 females with or without
RU486-mediated transgene induction from day 30 to day 37. n= 5 biological replicates with three individual ﬂies per replicate; ***p< 0.001 and **p< 0.01;
one-way ANOVA/Bonferroni’s multiple comparisons test. Boxplots b display the ﬁrst and third quartile, with the horizontal bar at the median and whiskers
showing the most extreme data point, which is no more than 1.5 times the interquartile range from the box. Bars h depict mean± s.d. RU486 was provided
in the media at a concentration of 25 μg/ml for a–e, g, h and 50 μg/ml for f
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an agar-only diet to induce starvation in aged ﬂies (Fig. 2e). This
improvement in starvation resistance was linked to increased
triglyceride (TAG) stores (Fig. 2f). Several interventions that
promote longevity, such as dietary restriction, are frequently
associated with reproductive tradeoffs35. In contrast, short-term,
midlife Drp1 induction increased fecundity in aged ﬂies (Fig. 2g).
Aging is associated with a loss of tissue homeostasis, resulting
in a decline in organ function. Recent work has shown that loss
of intestinal barrier function is an evolutionarily conserved
biomarker of aging36–40. To determine whether promoting
mitochondrial ﬁssion in midlife can delay the onset of intestinal
pathology, we examined intestinal barrier function in aging ﬂies
with and without midlife Drp1 induction. Loss of intestinal
integrity can be assayed in living ﬂies by monitoring the
presence of non-absorbed dyes outside of the digestive tract
post-feeding36, 41 (Fig. 2h). Remarkably, we observed a delay in
the onset of intestinal barrier dysfunction upon Drp1 induction
from day 30 onwards (Fig. 2h), indicating a delay in intestinal
aging at the tissue level. Collectively, these data demonstrate that
promoting Drp1-mediated mitochondrial ﬁssion in midlife
improves healthspan and delays the onset of pathology linked
to aging. Consistent with these ﬁndings, we observed that
inhibiting mitochondrial ﬁssion or promoting mitochondrial
fusion in midlife accelerates age-onset pathology. More speciﬁ-
cally, either Drp1K38A expression (Supplementary Fig. 2g) or
upregulation of dMfn (Supplementary Fig. 2h) in midlife confers
early-onset intestinal barrier dysfunction. Feeding RU486 to
control ﬂies did not alter feeding behavior, spontaneous physical
activity, loss of intestinal integrity, fecundity, or starvation
sensitivity (Supplementary Fig. 2a–f).
Midlife Drp1 induction improves mitochondrial function in
aged ﬂies. To better understand the interplay between mito-
chondrial dynamics and aging, we used immunoﬂuorescence (IF)
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Fig. 2Midlife Drp1 induction delays age-onset pathology and prolongs healthspan. a Capillary feeding assay (CAFE) of 37 day old daGS>UAS-Drp1 females
with or without RU486-mediated transgene induction from day 30 to day 37. n= 8 vials of 10 ﬂies per condition; p> 0.05 and is non-signiﬁcant (n.s.);
two-tailed unpaired t-test. b, c Spontaneous physical activity b of 37 day old daGS>UAS-Drp1 females with or without RU486-mediated transgene
induction from day 30 to day 37. Quantiﬁcation of total activity per ﬂy per hour c from spontaneous activity graphs. n= 3 vials of 10 ﬂies per condition;
**p< 0.01; two-tailed unpaired t-test. d Climbing index as a measure of endurance of 37 day old daGS> UAS-Drp1 females with or without RU486-
mediated transgene induction from day 30 to day 37. n= 90 ﬂies per condition; ∗p< 0.05; two-tailed Mann–Whitney test. e Survival curves without food of
37 day old daGS>UAS-Drp1 females with or without RU486-mediated transgene induction from day 30 to day 37. p< 0.01; log-rank test; n= 100 ﬂies.
f Whole body lipid stores of 37 day old daGS>UAS-Drp1 females with or without RU486-mediated transgene induction from day 30 to day 37. n= 5
biological replicates with three ﬂies per replicate; *p< 0.05; two-tailed unpaired t-test. g Fecundity of daGS>UAS-Drp1 females with or without RU486-
mediated transgene induction from day 30 to day 37. n= 630 ﬂies on day 10; *p< 0.05; one-way ANOVA/Bonferroni’s multiple comparisons test.
h Intestinal integrity during aging of daGS> UAS-Drp1 females with or without RU486-mediated transgene induction since midlife (day 30) onwards.
n= 448 ﬂies on day 10; **p< 0.01, *p< 0.05; one-way ANOVA/Bonferroni’s multiple comparisons test. Bars a, c and d depict mean± s.d. and bars
g, h depict mean± s.e.m. Boxplots f display the ﬁrst and third quartile, with the horizontal bar at the median and whiskers showing the most extreme data
point, which is no more than 1.5 times the interquartile range from the box. RU486 was provided in the media at a concentration of 25 μg/ml
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00525-4
4 NATURE COMMUNICATIONS | 8:  448 |DOI: 10.1038/s41467-017-00525-4 |www.nature.com/naturecommunications
microscopy and electron microscopy (EM) to examine age-
related alterations in mitochondrial morphology in ﬂight muscle.
Using both approaches, we observed that in midlife (day 28)
(Fig. 3b, f) the mitochondria are more elongated and less circular
than in young muscle tissue (10 day old) (Fig. 3a, e). This shift in
mitochondrial morphology becomes more pronounced at day 37
(Fig. 3c, g) suggesting an increase in fusion/decrease in ﬁssion. To
examine the generality of this ﬁnding, we examined age-related
alterations in mitochondrial morphology in an independent
control laboratory strain, wdahomey, and conﬁrmed a midlife shift
toward a more elongated mitochondrial morphology in aged
ﬂight muscle (Supplementary Fig. 3a, b). To determine whether
this age-related shift in mitochondrial dynamics was linked to
altered expression of Drp1, we examined Drp1 expression levels
during aging. We observed that an age-related decline in Drp1
expression accompanies the shift toward a more elongated, less
fragmented mitochondrial morphology (Supplementary Fig. 3c).
To gain insight into whether this shift in mitochondrial
morphology is linked to altered mitochondrial function, we
examined mitochondrial membrane potential using the potentio-
metric dye TMRE. Importantly, we observe that the accumulation
of elongated mitochondria is linked to a signiﬁcant decrease in
TMRE ﬂuorescence in aged ﬂight muscle (Fig. 3i–k). Remarkably,
we ﬁnd that short-term, midlife induction (day 30–37) of Drp1
restores mitochondrial morphology, including cristae ultrastruc-
ture, to a more youthful state (compare Fig. 3d with 3a–c and
Fig. 3h with 3e–g); quantiﬁcation in Fig. 3m, n). Furthermore, we
ﬁnd that midlife induction of Drp1 restores a fragmented
mitochondrial network, containing highly active mitochondria
reminiscent of young tissue (compare Fig. 3l with 3i–k;
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quantiﬁcation Fig. 3o). Together, these ﬁndings indicate that the
midlife shift in mitochondrial morphology, toward more
elongated, less circular mitochondria, contributes to the accu-
mulation of depolarized mitochondria in aged ﬂight muscle.
Critically, upregulating Drp1 expression in midlife, for 7 days,
rejuvenates mitochondrial morphology and function. RU486 had
no impact on mitochondrial morphology or TMRE ﬂuorescence
in control ﬂies (Supplementary Fig. 3d–g).
Next, we set out to examine the impact of midlife Drp1
induction on additional markers of mitochondrial health and
function in aged ﬂight muscle. First, we observed a signiﬁcant
increase in complex I enzymatic activity following short-term
(7 days) induction of Drp1 (Fig. 4a). To build upon this ﬁnding,
oxidative phosphorylation (OXPHOS) and electron transport
system (ETS) capacities were measured, in permeabilized muscle
bundles in situ, using high-resolution respirometry. We observed
a decline in OXPHOS activity and ETS capacity in aged ﬂies
(Supplementary Fig. 4a). Upregulation of Drp1 throughout
adulthood did not signiﬁcantly improve mitochondrial respira-
tory activity (Supplementary Fig. 4b). However, promoting Drp1-
mediated mitochondrial ﬁssion from midlife onwards resulted in
an increase in OXPHOS capacity at day 44, and an increase in
overall ETS capacity and the ﬂux control ratio for Complex I on
days 37 and 44 (Fig. 4b). In addition, we validated that promoting
Drp1-mediated mitochondrial ﬁssion from midlife onwards
improved mitochondrial function in brain tissue. More speciﬁ-
cally, we observed that 7 days of Drp1 induction in midlife (day
30–37) resulted in an increase in OXPHOS capacity, an increase
in overall ETS capacity and the ﬂux control ratio for Complex I in
head samples (Supplementary Fig. 4c). Next, we set out to
determine whether short-term, midlife Drp1 induction impacts
mitochondrial reactive oxygen species (ROS) levels. Following
7 days of Drp1 induction in midlife, we observed reduced
mitochondrial ROS levels in aged ﬂight muscle (Fig. 4c, d,
Supplementary Fig. 4d). Taken together, our data show that
promoting mitochondrial ﬁssion in midlife improves multiple
markers of mitochondrial function and reduces mitochondrial
ROS levels. RU486 had no signiﬁcant effect on Complex I
enzymatic activity or mitochondrial ROS levels in control ﬂies
(Supplementary Fig. 4e–g).
In recent years, considerable attention has been paid to the
concept of mitohormesis42. Indeed, studies in diverse organisms
have shown that certain perturbations that impair mitochondrial
function can promote longevity through mechanisms that may
involve elevated mitochondrial ROS and induction of the
mitochondrial unfolded protein response (UPRmt)43–47. As noted
above, however, short-term, midlife Drp1 induction leads to
reduced mitochondrial ROS levels (Fig. 4c, d). In addition,
we failed to detect an induction of UPRmt genes following
midlife Drp1 induction (Fig. 4e). These data indicate that midlife
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Drp1-mediated improvements in mitochondrial function and
organismal health are not mediated via mitohormesis. RU486
had no impact on UPRmt gene expression in control ﬂies
(Supplementary Fig. 4h).
Midlife Drp1 induction improves proteostasis in aged ﬂies.
Mitochondrial dysfunction and loss of protein homeostasis
(proteostasis) are two key hallmarks of aging1. However, the
relationship between these two hallmarks of aging is not well
understood. As noted above, we ﬁnd that promoting Drp1-
mediated mitochondrial ﬁssion in midlife improves mitochon-
drial function in aged ﬂies. To determine whether midlife Drp1
induction could impact proteostasis in aged animals, we char-
acterized the deposition of protein aggregates in aged ﬂight
muscle by IF microscopy. As previously reported18, 48, we
observed that Drosophila ﬂight muscles accumulate aggregates of
ubiquitinated proteins during aging (Fig. 5a–c), consistent with a
loss of proteostasis. Remarkably, short-term, midlife induction
(days 30–37) of Drp1 resulted in reduced levels of protein
aggregates in aged muscle (Fig. 5d, quantiﬁcation in Fig. 5i) and
aged brain tissue (Fig. 5k–m, quantiﬁcation in Fig. 5n). To further
validate our ﬁndings, we examined the impact of inhibiting
mitochondrial ﬁssion/promoting mitochondrial fusion in midlife
on proteostasis. Importantly, we observed that expressing a
dominant-negative Drp1 (Drp1K38A) transgene from midlife
onwards impairs proteostasis (Fig. 5e–h, j) and upregulation of dMfn
in midlife also impairs proteostasis (Supplementary Fig. 5a, b).
Recently, it has been reported that there is an over-
representation of mitochondrial proteins in the insoluble protein
fraction from aged animals49, 50. Interestingly, we observed that
short-term, midlife Drp1 induction leads to reduced levels of
ubiquitinated proteins in the mitochondrial fraction from aged
ﬂies (Fig. 5o, p, Supplementary Fig. 5e–g). Taken together, our
ﬁndings reveal that the midlife shift toward more elongated
mitochondria, in ﬂight muscle, contributes to age-onset proteo-
toxicity. Critically, short-term, midlife induction of Drp1
improves proteostasis in aged animals. RU486 had no signiﬁcant
impact on the accumulation of protein aggregates in control ﬂies
(Supplementary Fig. 5c, d).
Midlife Drp1 induction facilitates mitophagy in aged ﬂies.
To further understand the impact of promoting mitochondrial
ﬁssion in midlife on mitochondrial homeostasis, we examined
markers of mitochondrial content following Drp1 induction.
Short-term, midlife induction of Drp1 (days 30–37) resulted in
lower levels of some respiratory chain subunit proteins (Fig. 6a, b
and Supplementary Fig. 6a) and lower mitochondrial DNA levels
in aged ﬂight muscle (Fig. 6c, d). Furthermore, short-term midlife
induction of Drp1 correlated with lower levels of dMfn,
a degradation target of Parkin8, in the mitochondrial fraction
from aged ﬂies (Fig. 6e, f and Supplementary Fig. 6d). A possible
explanation for these ﬁndings is that midlife Drp1 induction
facilitates mitophagy and/or promotes selective turnover of some
respiratory chain subunits. Indeed, recent work has shown that
some mitochondrial respiratory chain proteins appear to be
selectively routed for autophagosomal degradation by the PINK1-
Parkin pathway51. To test the idea that midlife Drp1 induction
facilitates mitophagy, we examined aged ﬂight muscle for
co-localization of autophagy markers with mitochondria. Short-
term, midlife Drp1 induction (day 30–33) resulted in a signiﬁcant
increase in the co-localization of Atg8a/LC3 with mitochondria
(Fig. 6g, h). In mammalian cells, the ubiquitin-binding autophagy
adaptor protein p62/SQSTM1 accumulates on dysfunctional
mitochondria52 and has been proposed to facilitate recruitment
of damaged mitochondria to autophagosomes6. Furthermore,
recent work has shown that Refractory to Sigma P, ref(2)P, the
single Drosophila orthologue of p62 plays a critical role in the
PINK1-Parkin mitophagy pathway53, 54. Impaired autophagy
is associated with increased levels of p62 in mammals and
Drosophila55, indicating that levels of p62 reﬂect autophagic
status. To gain further insight into age-related changes in mito-
chondrial homeostasis, we examined ref(2)P co-localization with
mitochondria in aging ﬂight muscle. We observed a striking
accumulation of ref(2)P co-localized with mitochondria in midlife
(from day 28 to day 37), consistent with a decline in mitophagy in
aged muscle (Fig. 6i, j). Importantly, short-term, midlife induc-
tion of Drp1 (day 30–37) prevented the accumulation of ref(2)P
co-localized with mitochondria during aging (compare Fig. 6j, k
and quantiﬁcation of p62 levels in Fig. 6l). To conﬁrm this
ﬁnding, we examined ref(2)P levels speciﬁcally in the mito-
chondrial fraction from aged ﬂies. Short-term, midlife Drp1
induction (day 30–37) resulted in reduced ref(2)P levels in the
mitochondrial fraction from aged ﬂies (Fig. 6m, n and Supple-
mentary Fig. 6g). Together, these ﬁndings suggest that the midlife
shift toward more elongated, less circular mitochondria, in ﬂight
muscle, contributes to a decline in mitophagy. Short-term Drp1
induction in midlife, for 7 days, promotes mitochondrial frag-
mentation and facilitates mitophagy. RU486 had no signiﬁcant
impact on mitochondrial DNA levels in aged ﬂight muscle,
co-localization of Atg8a/LC3 with mitochondria and accumula-
tion of ref(2)P co-localized with mitochondria (Supplementary
Fig. 6b, c, e, f, h and i).
Midlife Drp1 induction requires autophagy to prolong lifespan.
To seek evidence for a causal role for autophagy in Drp1-
mediated longevity, we set out to directly manipulate Atg1,
a Ser/Thr protein kinase involved in the initiation of autopha-
gosome formation56. More speciﬁcally, we inhibited Atg1 by
RNAi from midlife onwards in ﬂies with increased Drp1-
mediated mitochondrial ﬁssion and compared survivorship to
ﬂies with increased Drp1-mediated mitochondrial ﬁssion alone
(Fig. 7a–e). We found that induced RNAi of Atg1 in midlife
reduced ATG8a/LC3 levels in aged ﬂight muscle (Fig. 7b, d) and
suppressed the lifespan extension associated with midlife Drp1
induction (Fig. 7e, Supplementary Fig. 7a). Inducing RNAi
of Atg1 in midlife did not shorten lifespan in control ﬂies
(Supplementary Fig. 7b). These results demonstrate that the
lifespan-extending effects of promoting Drp1-mediated mito-
chondrial ﬁssion in midlife depend upon the autophagy pathway.
In a similar fashion, we ﬁnd that induced RNAi of Atg1 in midlife
suppressed the lifespan extension associated with midlife RNAi of
dMfn (Supplementary Fig. 7c).
Next, we set out to determine whether autophagy is required
for Drp1-mediated improvements in mitochondrial function in
middle-aged ﬂies. We found that induced RNAi of Atg1 in midlife
suppressed the increase in mitochondrial respiratory function,
complex I activity and reduced ROS levels associated with midlife
Drp1 induction (Fig. 7f–h). Finally, we set out determine whether
autophagy was involved in Drp1-mediated improvements in
proteostasis in aged animals. Importantly, we found that induced
RNAi of Atg1 in midlife suppressed the Drp1-mediated reduction
in protein aggregates in aged muscle (Fig. 7i, j). Interestingly,
we also observed that promoting Drp1-mediated mitochondrial
ﬁssion in the context of induced RNAi of Atg1 in midlife leads to
increased levels of ubiquitinated proteins in the mitochondrial
fraction from aged ﬂies (Fig. 7k, l; Supplementary Fig. 7d).
Taken together, our data indicate that the anti-aging,
prolongevity effects of promoting mitochondrial ﬁssion, in
middle-aged animals, is dependent upon the activity of the
autophagy pathway.
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Discussion
One of the major goals of geroscience research is to identify
interventions that can be targeted to aged organisms to delay the
onset of pathology and, thereby, prolong healthy lifespan57.
Ideally, such interventions would not need to be applied for the
long-term. In this study, we have demonstrated that short-term,
midlife induction of Drp1, a Dynamin-related protein that cata-
lyzes mitochondrial ﬁssion, can extend lifespan in both male and
female Drosophila. Moreover, we ﬁnd that short-term induction
of Drp1, in middle-aged ﬂies, delays the onset of intestinal
pathology and improves additional markers of organismal health
in aged ﬂies. Reports of the impact of alterations of mitochondrial
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dynamics on lifespan in different model organisms have not
always been consistent. Previous studies in fungal models have
reported that reducing mitochondrial ﬁssion can extend life-
span58. In C. elegans, loss of Drp1 had no impact on lifespan in
wild-type worms, but rather Drp1 inactivation was shown to
speciﬁcally synergize with insulin-like signaling mutants to
extend lifespan59. Furthermore, reducing Drp1 levels has been
reported to protect against certain neurodegenerative disease
models60, 61. A major difference between these previous studies
and our current study is that we have manipulated Drp1
expression in middle-aged animals. In addition, we ﬁnd that
RNAi of the mitochondrial fusion-promoting factor dMfn from
midlife onwards similarly prolongs lifespan. Taken together, these
ﬁndings reveal that promoting a shift in mitochondrial dynamics
toward increased ﬁssion/decreased fusion in middle-aged animals
prolongs organismal health and lifespan.
It has been shown previously that promoting mitochondrial
ﬁssion rescues several degenerative phenotypes in PINK1 and
Parkin mutant ﬂies62–64. These data support the emerging model
that mitochondrial ﬁssion can facilitate mitophagy7, 11, 12, 27–29.
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However, little was known about the relationships between
mitochondrial dynamics, mitophagy, and aging. We have dis-
covered that a midlife shift toward a more elongated mitochon-
drial morphology is associated with two major hallmarks of aging,
mitochondrial dysfunction and loss of proteostasis, in aged ﬂight
muscle. Short-term induction of Drp1, in midlife, rejuvenates
mitochondrial morphology and leads to improved mitochondrial
capacities for oxidative phosphorylation and electron transport
system ﬂux. These improvements in mitochondrial function,
mediated by midlife Drp1 induction, are linked to reduced
mitochondrial ROS. In addition, short-term, midlife Drp1
induction restores proteostasis in aged ﬂies. These data reveal that
the accumulation of elongated dysfunctional mitochondria, in
ﬂight muscle from middle-aged animals, contributes to age-onset
proteotoxicity. One potential explanation for this ﬁnding would
be that a midlife decline in mitophagy, due to a shift in mito-
chondrial dynamics, leads to the accumulation of insoluble or
aggregated mitochondrial proteins. One of the most pressing
future questions to emerge from our work concerns the
mechanisms that underlie the midlife shift toward a more elon-
gated mitochondrial morphology in aged muscle. It is tempting to
speculate that this may reﬂect a shift toward increased mito-
chondrial fusion, as a physiological adaption to age-onset mito-
chondrial damage. Indeed, fusion can mitigate the effects of
localized mitochondrial damage through the exchange of proteins
and lipids with other mitochondria as a form of complementa-
tion20. It will also be interesting to determine the precise
mechanisms by which promoting mitochondrial ﬁssion in aged
muscle leads to improved mitochondrial respiratory function.
Consistent with a model in which Drp1-mediated longevity is
linked to autophagy, we ﬁnd that disrupting Atg1 suppresses the
improvement in mitochondrial homeostasis, proteostasis and
extended lifespan associated with midlife Drp1 induction. As
Drp1 is also involved in the ﬁssion of peroxisomes65, however, it
is formally possible that altered peroxisome division may play a
role in Drp1-mediated longevity. Indeed, an interesting avenue
for future exploration would be to study the interplay between
mitochondrial morphology, peroxisomal morphology and aging.
An additional set of questions concern the relevance of our
ﬁndings to mammalian aging. Recent studies have reported a
decline in mitophagy in aged mammals15, 16 and disruptions in
mitophagy have been implicated in the pathophysiology of
cardiac senescence66 and a number of neurodegenerative dis-
orders8, 67. However, an understanding of the interplay between
mitochondrial dynamics and mitophagy during mammalian
aging is lacking. Indeed, studies of alterations in mitochondrial
morphology during mammalian aging have been inconclusive.
While a shift toward a more fragmented mitochondrial network
has been reported in skeletal muscle from animals of advanced
age68, several studies have reported larger and less circular
mitochondria in aged skeletal muscle, suggesting a shift toward
hyper-fused mitochondria69, 70. It has been suggested that these
seemingly contradictory results may be due to the fact that
denervation induces mitochondrial ﬁssion in muscle68, 71.
Therefore, studies examining muscles from very advanced age are
more likely to sample regions from denervated ﬁbers containing
a highly fragmented mitochondrial morphology. Indeed,
the studies ﬁnding more elongated mitochondria examined
younger animals69, 70 than the study reporting more ﬁssioned
mitochondria68. Moreover, reports of hyper-fused mitochondria in
muscle from middle-aged animals is consistent with observations
of so-called giant mitochondria in aged mammalian heart tissue72.
Therefore, it appears that the accumulation of elongated, less
circular mitochondria in midlife may also be a hallmark of
mammalian aging. Critically, manipulations that cause excessive
mitochondrial fusion, such as overexpression of dominant-negative
Drp121 or nutrient starvation73, preclude mitophagy in mamma-
lian cells. It will, therefore, be important to determine whether
promoting mitochondrial ﬁssion/inhibiting fusion in middle-aged
mammals can improve mitochondrial homeostasis and delay the
onset and progression of aging-related health decline.
Methods
Fly strains and media. UAS-Drp1-HA, UAS- Drp1K38A, and UAS-Mfn were pro-
vided by J. Chung (Korea Advanced Institute of Science and Technology, Republic
of Korea). An independent UAS-Drp1 transgene was provided by Mel Feany
(Harvard Medical School). UAS-dMfn-RNAi and UAS-Atg1-RNAi lines were
received from the Vienna Drosophila RNAi Center, daughterless-Gene-Switch
(daGS) was provided by H. Tricoire (Université Paris Diderot–Paris7, Paris,
France), and Elav–GeneSwitch (ElavGS) was provided by H. Keshishian (Yale
University, New Haven, CT). white1118 was provided by the Bloomington Stock
Center. Flies were reared in vials containing cornmeal medium (1% agar, 3% yeast,
1.9% sucrose, 3.8% dextrose, 9.1% cornmeal, 1% acid mix, and 1.5% methylpar-
aben, all concentrations given in wt/vol).
Lifespan analysis. Flies were collected under light nitrogen-induced anesthesia
and housed at a density of 30 male or female ﬂies per vial. All ﬂies were kept in a
humidiﬁed, temperature-controlled incubator with 12 h on/off light cycle at 25 °C.
RU486 was dissolved in ethanol and administered in the media while preparing
food. Flies were ﬂipped to fresh vial every 2–3 days and scored for death.
Starvation resistance assay. Female ﬂies were aged for 37 days in vials containing
cornmeal medium with or without RU486 addition from 30 days. Then ﬂies were
transferred to 1% agar solution in a humidiﬁed, temperature-controlled incubator
with 12 h on/off light cycle at 25 °C. Percentage of survival was measured every day,
with survivors transferred to fresh vial every 2–3 days.
Fecundity assay. Flies were collected and kept in a humidiﬁed, temperature-
controlled incubator with 12 h on/off light cycle at 25 °C. Eggs laid per ﬂy in 24 h
were counted.
Fig. 7 Autophagy is required for Drp1-mediated longevity. All experiments, except e, were carried out on day 37 in daGS, UAS-Atg1-RNAi>UAS-Drp1
females with or without RU486-mediated transgene induction from day 30 to 37. a qPCR analyses of Atg1 and Drp1 mRNA levels. n= 5 replicates (three
ﬂies per replicate); *p< 0.05, **p< 0.01; two-tailed Mann–Whitney test. b–d Immunostaining b of indirect ﬂight muscles showing mitochondria (green
channel, anti-ATP5a) and Atg8a foci (red channel, anti-Atg8a). Quantiﬁcation of mitochondrial size c and total number of Atg8a foci d; n= 6–10 ﬂies;
**p< 0.01, ***p< 0.001; two-tailed unpaired t-test. e Survival curves with or without RU486-mediated transgene induction from day 30 onwards. The
shaded area indicates the duration of Drp1 activation and Atg1 RNAi. p= 0.96, log-rank test; n> 288 ﬂies. f In situ respirometry of permeabilized muscles to
assess the capacity for oxidative phosphorylation (OXPHOS) and Electron Transport System (ETS) ﬂux, and the ﬂux control ratio of Complex I by rotenone
inhibition. n= 6 replicates (two thoraces per replicate); n.s. indicates not signiﬁcant; two-tailed unpaired t-test. g, h Staining of indirect ﬂight muscles
g showing mitochondria (green channel, Mitotracker green staining) and levels of superoxide radicals (red channel, staining with MitoSOX reagent).
Quantiﬁcation of free superoxide radicals h; n= 12 replicates; n.s. indicates not signiﬁcant; two-tailed unpaired t-test. i, j Immunostaining of indirect
ﬂight muscles j showing protein polyubiquitinated aggregates (red channel, muscles stained with phalloidin/F-actin and green channel, antipolyubiquitin).
i Quantiﬁcation of polyubiquitin aggregates in muscle (as shown j); n= 16 ﬂies; **p< 0.01; two-tailed unpaired t-test. k, l Western blot k detection of
total ubiquitin-conjugated proteins in isolated mitochondria. Densitometry of ubiquitin blots l from mitochondrial pellet; n= 8 replicates, 25 ﬂies per
replicate; *p< 0.05; two-tailed unpaired t-test. Bars a, d and l depict mean± s.d. Boxplots c, f, h and i display the ﬁrst and third quartile, with the horizontal
bar at the median. Scale bar is 5 µm. RU486 was provided in the media at a concentration of 25 μg/ml
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Analysis of food intake. Quantiﬁcation of food intake was assayed at 37 days of
age using CApillary FEeding (CAFE) assay as described previously18 with mod-
iﬁcations. Brieﬂy, 10 ﬂies were placed in vials with wet tissue paper as a water
source and a capillary food source [5% sucrose, 5% yeast extract, 2.5% FD&C Blue
No. 1 (SPS Alfachem)]. Feeding was monitored from 11 am until 30 min after lights
off (7:30 pm) in the evening, with capillaries being replaced regularly and feeding
amounts recorded every 2–3 h.
Physical activity. Physical activity was analyzed in two different ways. Sponta-
neous physical activity assay: 10 adult female ﬂies were placed in a Drosophila
activity monitor (TriKinetics). Movements were recorded continuously under
normal culturing conditions for 36 h on a 12-h:12-h dark:light cycle. Bar graphs
represent mean activity per ﬂy per hour for 36 h and the scatter plot shows
spontaneous activity per ﬂy during 12-h:12-h dark:light cycle. Triplicate samples
were used for each activity measurement. Climbing activity: ~100 adult female ﬂies
were placed in 100 ml glass cylinder. Cylinder was tapped quickly and ﬂies were
allowed to settle for 2 min. This step was repeated eight times. Then cylinder was
quickly tapped and after 1 min, the number of ﬂies in upper, middle, and lower
1/3rd part of the cylinder were recorded.
Quantiﬁcation of triglycerides. Lipids were extracted from three whole female
ﬂies in a chloroform:ethanol solution (2:1 vol/vol). The nonpolar lipids (fatty acid,
triacylglycerol) were separated by thin-layer chromatography with n-hexane, die-
thylether, glacial acetic acid solution (70:30:1, vol/vol/vol). Plates were air-dried
and stained with 0.2% amido black 10B in 1M NaCl and lipid bands were
quantiﬁed by photo densitometry using ImageJ and normalized to body weight.
Intestinal barrier dysfunction (Smurf) assay. The intestinal barrier dysfunction
(Smurf) assay was performed similarly to36. Flies were aged on standard medium
until the day of the Smurf assay. Dyed medium was prepared using standard
medium with F&D blue dye #1 (purchased from SPS Alfachem) added at a
concentration of 2.5% wt/vol. Flies were transferred onto dyed medium for 16 h
and a ﬂy was counted as a Smurf when dye coloration was observed outside the
digestive tract.
Antisera generation. Rabbit polyclonal antiserum recognizing Drosophila Atg8a
and refractory to Sigma P, ref(2)P, the single Drosophila orthologue of p62 were
generated by a commercial source (AbMart Inc., China) using synthetic peptides
corresponding to sequences in these proteins (Atg8a: MKFQYKEEHAFEKRR; p62:
VNTDQSVPRTED). The serum was antigen-afﬁnity-puriﬁed and speciﬁcity of the
antibody was shown by immunostaining (Supplementary Fig. 8a, b).
Immunostaining and image analysis. Flies were ﬁxed for 20 min with 3.7%
formaldehyde in PBS and hemi-thoraces were dissected. For brain immunostain-
ing, brains were dissected and ﬁxed for 20 min with 3.7% formaldehyde in PBS.
Samples were then rinsed three times with 0.2% Triton X-100 in PBS (PBST) and
blocked for 1 h at room temperature in 3% BSA in PBST. Primary antibodies were
diluted 1:250 in 5% BSA in PBST and incubated overnight at 4 °C. Primary anti-
bodies used were: rabbit anti-Drp1 (a generous gift from Dr. Leo Pallanck11),
mouse anti-ATP5A (15H4C4, Abcam), anti-ds DNA (ab27156, Abcam), anti-HA
(HA.11 Clone 16B12 Monoclonal Antibody, Covance), Mono- and poly-
ubiquitinylated conjugates monoclonal antibody (FK2) (BML-PW8810, Enzo),
rabbit anti-ATG8a (see antisera generation) and p62 (see antisera generation).
Samples were then rinsed thrice with PBST and incubated with secondary anti-
bodies and/or stains for 3 h at room temperature. Secondary antibodies and stains
were diluted 1:250 in 5% BSA in PBST and incubated for 3 h at room temperature.
Secondary antibodies used were: anti-rabbit or anti-mouse AlexaFluor-488
(Invitrogen); anti-rabbit or anti-mouse AlexaFluor-555 (Invitrogen); To-Pro-3
DNA stain (Invitrogen); phalloidin AlexaFlour-568 (Invitrogen). Samples were
then rinsed three times and mounted in Vectashield mounting medium (Vector
Labs) and imaged using Zeiss single point LSM 5 exciter confocal microscope.
Mitochondrial or protein aggregates area measurements were done using ImageJ.
Analyze particle feature of ImageJ was used to measure the area of mitochondria or
the protein aggregate. For protein aggregates, this value was corrected for the area
of muscle and represented as % protein aggregates per deﬁned muscle area.
Electron microscopy. Standard procedure for electron microscopic (EM) analysis
was carried out as described in ref. 74 with slight modiﬁcations. Thoraces were ﬁxed
in 2% glutaraldehyde and 2% formaldehyde in 0.1 M sodium phosphate buffer (PB)
containing 0.9% NaCl overnight at 4 °C. Thoraces were then bisected and post-
ﬁxed in 1% osmium tetroxide in PB, treated with 0.5% uranyl acetate, and dehy-
drated through a graded series of ethanol concentrations. After inﬁltration with
Eponate 12 resin, the samples were embedded in fresh Eponate and polymerized
overnight. Semi-thin sections (1.5 µm) were cut on an ultramicrotome and stained
with toluidine blue. The muscle area of interest was identiﬁed from these sections.
For EM, sections of 50 nm thickness were prepared from the identiﬁed area, placed
on formvar coated copper grids and stained with uranyl acetate and Reynolds’ lead
citrate. The grids were examined using a JEOL 100CX transmission electron
microscope at 60 kV(Electron Microscopy Facility, UCLA Brain Research Insti-
tute). For quantiﬁcation, ImageJ was used to measure mitochondrial perimeter
from electron micrographs taken under identical conditions and magniﬁcation.
TMRE staining. Flies were anesthetized and hemi-thoraces were dissected in cold
Drosophila Schneider’s Medium (DSM) (Thermo Fisher Scientiﬁc). Hemi-thoraces
were then incubated in TMRE staining solution, consisting of 100 nM of TMRE
(Thermo Fisher Scientiﬁc) in DSM, for 12 min at room temperature. Samples were
rinsed two times for 30 s each wash with a solution consisting of 25 nM of TMRE
in DSM. Samples were quickly mounted in the same medium onto the slide and
imaged within 15–20 min using identical setting on the confocal microscope.
Quantiﬁcation of TMRE staining is done using Image J in which mean intensity
values for the TMRE stains were quantiﬁed.
Mitochondria puriﬁcation. Samples were gently crushed in chilled mitochondrial
isolation medium (MIM) [250Mm sucrose, 10 mM Tris-HCl (pH 7.4), 0.15 mM
MgCl2] using a plastic pestle homogenizer and then spun twice at 500 × g for 5 min
at 4 °C to remove debris. The supernatant was then spun at 5000 × g, for 5 min at
4 °C. The pellet, containing the mitochondria, was stored at −80° C.
Complex I assay from mitochondrial pellet. Complex I assay was performed
as described in ref. 18. The mitochondrial pellet was washed with MIM and
resuspended in 100 μl of MIM or assay buffers. Dilutions of mitochondrial pre-
parations were resuspended in NADH dehydrogenase assay buffer (1 × PBS, 0.35%
BSA, 200 μM NADH, 240 μM KCN, 60 μM 2,6-dichloroindophenol sodium salt
hydrate (DCIP), 70 μM decylubiquinone, 25 μM antimycin A) containing 2 μM
rotenone or ethanol. Complex I activity was measured as the rate of decrease in
absorbance at 600 nm using an Epoch plate-reading spectrophotometer (BioTek).
In situ muscle and head respirometry. Mitochondrial respiration was measured
in isolated thoraces or heads in situ at 25 °C in hyperoxygenated media (550–350
nmol/ml) using high-resolution respirometry (O2k, Oroboros, AT). After rapid
dissection, whole thoraces were permeabilized in saponin (50 µg/ml) prepared in
ice-cold BIOPS for 15 min (BIOPS: 2.77 mM CaK2 EGTA, 7.23 mM K2 EGTA,
5.77 mM Na2 ATP, 6.56 mM MgCl2·6H2O, 20 mM taurine, 15 mM Na2 PCr,
20 mM imidazole, 0.5 mM DTT, 50 mM MES hydrate), followed by 2 × 5 min
washes in respiration medium (MiR05: 0.5 mM EGTA, 3 mM MgCl2, 60 mM
K-lactobionate, 20 mM taurine, 10 mM KH2PO4, 20 mM HEPES, 110 mM sucrose,
and 1 g/l BSA, pH 7.1). After washing, thoraces were gently dried on ﬁlter paper
and weighed before being placed into the respirometer chambers (2 ﬂies/chamber).
Similarly for head respirometry, 10 heads were dissected in saponin (25 µg/ml)
prepared in ice-cold BIOPS washed quickly and placed inside the respirometer
chamber. Oxidative phosphorylation (OXPHOS) and electron transport system
(ETS) capacities were measured using a modiﬁed substrate-uncoupler-inhibitor-
titration protocol that consisted of multiple sequential injections at saturating
concentrations [Bratic, A. et al, 2015 and Pichaud, N. et al., 2011]. To achieve
maximal ADP-stimulated respiration from electron ﬂux through complex I, 5 mM
pyruvate, 5 mM proline, 2 mM malate, 10 mM glutamate, and 2.5 mM ADP were
added to the chambers for thoraces and 5 mM pyruvate, 5 mM proline, 2 mM
malate, and 2.5 mM ADP were added for the heads. To achieve maximal con-
vergent electron ﬂux through both complex I and II (i.e., OXPHOS capacity),
15 mM glycerol-3-phosphate and 10 mM succinate were injected into each
chamber. To assess the functional integrity of the outer mitochondrial membrane,
10 µM cytochrome c was added. Samples that increased OXPHOS by >15% during
this step were deemed to have poor integrity and rejected on the basis of quality
control [Kuznetsov, A.V. et al., 2008]. Non-phosphorylating LEAK respiration in
the presence of high adenylates (LOmy) was evaluated by inhibiting ATP synthase
with 2.5 µM oligomycin. To assess electron transport system (ETS) capacity, 0.5 µM
carbonylcyanide p-triﬂuoromethoxy-phenylhydrazone (FCCP) was titrated in 1 μl
steps. 0.5 µM rotenone was then added to inhibit complex I and calculate the
complex I contribution to ETS capacity. Lastly, residual oxygen consumption
(non-mitochondrial respiration) was determined by adding 2.5 µM Antimycin A to
inhibit complex III. The total assay time per sample was ~1.5 h. Oxygen ﬂux for
each respiratory state was adjusted for sample weight and corrected by subtracting
the non-mitochondrial respiration. The ﬂux control ratio for complex I was
calculated from the rate of oxidation after rotenone injection expressed as a
fraction of ETS capacity (after FCCP steps), and subtracted from one.
MitoSox staining assay. Flies were anesthetized and hemi-thoraces were dissected
in cold Drosophila Schneider’s Medium (DSM) (Thermo Fisher Scientiﬁc).
Hemi-thoraces were then incubated in a staining solution consisting of 5 μM
MitoSOX Red (Thermo Fisher Scientiﬁc) and 100 nM MitoTracker Green (Thermo
Fisher Scientiﬁc) in DSM. Staining was done for 12 min at room temperature and
then samples were rinsed two times for 30 s each wash with DSM. Samples were
quickly mounted in DSM and imaged within 10–15 min using identical confocal
microscope settings. Quantiﬁcation of staining is done using Image J in which
mean intensity value for the MitoSOX stain was quantiﬁed.
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Quantitative real-time PCR. Total RNA was extracted using TRIzol reagent
(Invitrogen) following manufacturer protocols. Samples were treated with DNAse,
and then cDNA synthesis was carried out using the First Strand cDNA Synthesis
Kit from Fermentas. PCR was performed with Power SYBR Green master mix
(Applied Biosystems) on a BioRad Real-Time PCR system. Cycling conditions were
as follows: 95 °C for10 min; 95 °C for 15 s then 60 °C for 60 s, cycled 40 times.
Equalized amplicons of Actin5C were used as a reference to normalize. Primer
sequences were as follows:
Act5C, TTGTCTGGGCAAGAGGATCAG and ACCACTCGCACTTGCACT
TTC;
Drp1, ATTGTTGTTCTAGGCAGTCAG and GAACTCTTGCCGGAGCT
Hsp60, TGATGCTGATCTCGTCAAGC and TACTCGGAGGTGGTGTCCTC;
Hsp10, CCCGCATCTAGCGAGAATAG and CTCCTTTCGTCTTGGTCAGC;
Hsc70-5, GGAATTGATATCCGCAAGGA and TCAGCTTCAGGTTCATG
TGC;
Atg1, CGTCTACAAAGGACGTCATCGCAAGAAAC and CGCCAAGTCGC
CGCCATTGCAATACTC.
Western blot assay. Samples were collected and lysates were separated by SDS
page using standard procedures. Membranes were probed with antisera against
anti-actin (PA5-16914, Thermo Fisher Scientiﬁc), anti-HA (HA.11 Clone 16B12
monoclonal Antibody, Covance), Anti-VDAC1/Porin (ab14734, Abcam), anti-p62
(see antisera generation), anti-dMfn (a generous gift from Dr. Leo Pallanck),
MitoProﬁle Total OXPHOS Rodent WB Antibody Cocktail (ab110413, Abcam)
and anti-Ubiquitin (P4D1, mouse mAb no. 3936 from Cell Signaling). All primary
antibodies were used in 1:2500 dilutions except anti-actin where dilution was
1:15,000. The rabbit antibodies were detected using horseradish peroxidase-
conjugated anti-rabbit IgG antibodies (1:2000 dilution; Sigma). The mouse anti-
bodies were detected using horseradish peroxidase-conjugated anti-mouse IgG
antibodies (1:2000 dilution; Sigma). Amersham ECL Prime Western Blotting
Detection Reagent (GE life sciences) was used to visualize the presence of horse-
radish peroxidase, and the chemiluminescent signal was recorded using Syngene
Pxi Western Blot Imager. Image analysis was done using ImageJ.
Statistical analysis. Prism5 (GraphPad) was used to perform the statistical ana-
lysis and graphical display of the data. Signiﬁcance is expressed as p values which
was determined with two-tailed, unpaired, parametric or non-parametric tests as
indicated in the ﬁgure legends unless otherwise stated in material and methods. For
two group comparisons: either unpaired t-test was used when data met criteria for
parametric analysis (normal distribution assessed by Shapiro-Wilk normality test
or Kolmogorov–Smirnov test using Prism5 and equal variance assessed by Fisher’s
exact test using excel) or Mann–Whitney U-test was used in case of non-
parametric analysis. For more than two group’s comparison ANOVA with Bon-
ferroni post hoc test was performed. Kruskal–Wallis with dunn’s post hoc test was
used when data did not meet requirements for parametric test. For comparison of
survival curves, Log-rank (Mantel-Cox) test was used.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author upon reasonable request.
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